AKEBIA THERAPEUTICS, INC. (AKBA) Shareholders’ equity 2016–2025
AKEBIA THERAPEUTICS, INC. (AKBA) shareholders’ equity at each fiscal year-end, per SEC filings.
$32.6MFY2025 · since FY2016: $68.1M → $32.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $32.6M | +166.3% |
| FY2024 | -$49.2M | -60.8% |
| FY2023 | -$30.6M | -684.8% |
| FY2022 | $5.2M | -92.9% |
| FY2021 | $74.0M | -69.7% |
| FY2020 | $244.4M | -37.8% |
| FY2019 | $392.9M | -38.2% |
| FY2018 | $635.9M | +418.8% |
| FY2017 | $122.6M | +79.9% |
| FY2016 | $68.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice